HR and benefits leaders today face a stark reality: you either have total control over your pharmacy spend, or you have none. As legacy, and some pass-through, models struggle to adapt to regulatory pressure and rising costs, how can employers distinguish between PBMs that are merely rebranding old tactics and those that have fundamentally re-engineered the cost-containment engine?

Join SmithRx experts Alissa Johnson, Vidya Drego, and Ty Perry for a candid breakdown of the market shifts requiring a new breed of PBM. From the "budgets vs. member experience" dilemma to the technical evolution of cost containment solutions, we explore how the Drug Pathways Engine is here to future-proof your benefits plan.

In this episode, we explore:

• What trends today are shaping the PBM landscape and why its reached a boiling point
• Why making the leap to a modern PBM has unprecedented ROI
• How SmithRx has engineered an innovative solution for sustainable savings improvements

Thank you to our guests, Vidya Drego and Ty Perry.

Watch the full audiovisual version of Full Disclosure on Youtube: https://www.youtube.com/playlist?list=PL8KOGXGVDmCYJgHewvjRWMogYmEkrsErv